NIHON CHOUZAI Co.,Ltd. Provides Consolidated Earnings Guidance for the First Half of Fiscal 2025 and the Full Year Ending March 31, 2025
April 30, 2024 at 02:00 am
Share
NIHON CHOUZAI Co.,Ltd. provided consolidated earnings guidance for the first half of fiscal 2025 and the full year ending March 31, 2025. For the first half, the company expects net sales of JPY 183,700 million, an Operating profit of JPY 2,300 million; Profit attributable to owners of the parent of JPY 1,200 million or JPY 40.11 per share.
For the full year, the company expects net sales of JPY 373,800 million, an Operating profit of JPY 6,400 million; Profit attributable to owners of the parent of JPY 3,700 million or JPY 123.67 per share.
NIHON CHOUZAI Co., Ltd is primarily engaged in the pharmacy business, the provision of staffing services, as well as the manufacture and sale of pharmaceutical products. The Company operates in three business segments. The Pharmacy segment is engaged in the operation of a chain of dispensing pharmacies. The Pharmaceutical Product Manufacturing and Distribution segment is engaged in the manufacture and nationwide sale of generic pharmaceutical products. The Healthcare Personnel Staffing Service segment is involved in the dispatching of pharmacists to various regional pharmacies.
NIHON CHOUZAI CO.,LTD. 
